EDITORIAL
Procalcitonin as a marker of bacterial infection in elderly patients
 
More details
Hide details
1
Dept of Pneumonology, Medical School, Democritus University of Thrace, Greece
 
 
Corresponding author
Demosthenes Bouros   

Dept. of Pneumonology, Medical School, Democritus University of Thrace, Alexandroupolis 68100, Greece
 
 
Pneumon 2014;27(1):13-15
 
KEYWORDS
 
REFERENCES (20)
1.
Muller B, White JC, Nylen ES, et al. Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab 2001;86:396-404.
 
2.
Jensen JU, Heslet L, Jensen TH, et al. Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 2006;34:2596-2602.
 
3.
Christ-Crain M, Muller B. Procalcitonin in bacterial infections- hype, hope, more or less? Swiss Med Wkly, 2005;135(31- 32):451-460.
 
4.
Muller B, Peri G, Doni A, et al. High circulating levels of the IL-1 type II decoy receptor in critically ill patients with sepsis: association of high decoy receptor levels with glucocorticoid administration. J Leukoc Biol 2002;72:643-649.
 
5.
de Kruif LL, Giebelen IA, Struck J, et al. The influence of corticosteroids on the release of novel biomarkers in human endotoxemia. Intensive Care Med 2008;34:518-522.
 
6.
Schuetz P, Chiappa V, Briel M, et al. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med 2011;171:1322-1331.
 
7.
Schuetz P, Muller B, Christ-Crain M, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev, 2012. 9: p. CD007498.
 
8.
Ackermann RJ, Monroe PW. Bacteremic urinary tract infection in older people. J Am Geriatr Soc 1996;44:927-933.
 
9.
Lee CC, IJ Chang, YC Lai, et al. Epidemiology and prognostic determinants of patients with bacteremic cholecystitis or cholangitis. Am J Gastroenterol 2007;102:563-569.
 
10.
Gutierrez F, Masia M. Improving outcomes of elderly patients with community-acquired pneumonia. Drugs Aging 2008;25: 585-610.
 
11.
Fernandez-Sabe N, Carratala J, Roson B, et al. Communityacquired pneumonia in very elderly patients: causative organisms, clinical characteristics, and outcomes. Medicine (Baltimore), 2003;82:159-69.
 
12.
Lee CC, Chen SY, Chang IJ, et al, Comparison of clinical manifestations and outcome of community-acquired bloodstream infections among the oldest old, elderly, and adult patients. Medicine (Baltimore), 2007;86:138-44.
 
13.
van Duin D. Diagnostic challenges and opportunities in older adults with infectious diseases. Clin Infect Dis 2012;54:973-978.
 
14.
Caterino JM, Scheatzle MD, Forbes ML, et al. Bacteremic elder emergency department patients: procalcitonin and white count. Acad Emerg Med 2004;11:393-396.
 
15.
Lai CC, Chen SY, Wang CY, et al. Diagnostic value of procalcitonin for bacterial infection in elderly patients in the emergency department. J Am Geriatr Soc 2010;58:518-522.
 
16.
Steichen O, Bouvard E, Grateau G, et al. Diagnostic value of procalcitonin in acutely hospitalized elderly patients. Eur J Clin Microbiol Infect Dis 2009;28:1471-1476.
 
17.
Stucker F, Herrmann F, Graf JD, et al. Procalcitonin and infection in elderly patients. J Am Geriatr Soc 2005;53:1392-1395.
 
18.
Dwolatzky T, Olshtain-Pops K, Yinnon AM, et al. Procalcitonin in the elderly: normal plasma concentrations and response to bacterial infections. Eur J Clin Microbiol Infect Dis 2005;24:763- 765.
 
19.
Lee SH, Chan RC, Wu JY, et al. Diagnostic value of procalcitonin for bacterial infection in elderly patients - a systemic review and meta-analysis. Int J Clin Pract 2013;67:1350-1357.
 
20.
Simon L, Gauvin F, Amre DK, et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis, 2004;39:206- 217.
 
eISSN:1791-4914
ISSN:1105-848X
Journals System - logo
Scroll to top